GENO — Genovis AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual income statement for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	93	102	158	130	129
Cost of Revenue
Gross Profit	81.3	87.4	143	115	116
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	68.5	94.1	104	84.6	108
Operating Profit	24.5	8.28	54.2	45.7	21.3
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	24.6	8	54.9	46.3	26.8
Provision for Income Taxes
Net Income After Taxes	24.8	11.2	61.5	32.9	23.5
Net Income Before Extraordinary Items
Net Income	24.8	11.2	61.5	32.9	23.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	24.8	11.2	61.5	32.9	23.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.381	0.259	0.939	0.503	0.357
Dividends per Share